Skip to content

ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: 20-F filed 2024-11-07

What ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED reported in its annual report (foreign private issuer) filed 2024-11-07 (fiscal FY 2024): 54 published measures, 193 facts as tagged in accession 0001079973-24-001482.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2024-11-07
Fiscal period
fiscal FY 2024
Accession
0001079973-24-001482 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-03-313,168,233USD
At 2023-03-312,133,728USD
At 2022-03-312,852,875USD
At 2021-03-313,457,596USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-03-313,387,027USD
At 2023-03-312,815,982USD
At 2022-03-311,911,475USD
At 2021-03-311,957,103USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-03-31-204,549USD
At 2023-03-31-698,879USD
At 2022-03-31941,400USD
At 2021-03-311,500,493USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2024-03-31271,869USD366
2022-04-01 to 2023-03-31-2,204,126USD365
2021-04-01 to 2022-03-31-1,125,565USD365
2020-04-01 to 2021-03-31-28,022USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-04-01 to 2024-03-31-745,816USD366
2022-04-01 to 2023-03-31-1,025,359USD365
2021-04-01 to 2022-03-31-255,747USD365
2020-04-01 to 2021-03-31309,195USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-04-01 to 2023-03-3122,369USD365
2021-04-01 to 2022-03-310USD365
2020-04-01 to 2021-03-315,632USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-04-01 to 2024-03-312,278,246USD366
2022-04-01 to 2023-03-311,662,600USD365
2021-04-01 to 2022-03-312,328,526USD365
2020-04-01 to 2021-03-311,635,420USD365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-04-01 to 2022-03-312,328,526USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-04-01 to 2024-03-31715,090USD366
2022-04-01 to 2023-03-311,295,763USD365
2021-04-01 to 2022-03-31263,042USD365
2020-04-01 to 2021-03-31-95,535USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-04-01 to 2023-03-31118,131USD365
2021-04-01 to 2022-03-310USD365
2020-04-01 to 2021-03-31-988USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-03-31-3,214,881USD
At 2023-03-31-3,517,091USD
At 2022-03-31-1,367,834USD
At 2021-03-31-242,269USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2024-03-3117,692,853shares366
2022-04-01 to 2023-03-3117,666,043shares365
2020-04-01 to 2021-03-3117,145,000shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-04-01 to 2024-03-3117,992,853shares366
2022-04-01 to 2023-03-3117,666,043shares365
2020-04-01 to 2021-03-3117,145,000shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-04-01 to 2024-03-31-0.02USD/shares366
2022-04-01 to 2023-03-310.12USD/shares365
2020-04-01 to 2021-03-310.16USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-04-01 to 2024-03-31-0.02USD/shares366
2022-04-01 to 2023-03-310.12USD/shares365
2020-04-01 to 2021-03-310.16USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-04-01 to 2024-03-31-594USD366
2022-04-01 to 2023-03-31-8,840USD365
2021-04-01 to 2022-03-3111,119USD365
2020-04-01 to 2021-03-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-03-312,395USD
At 2023-03-314,772USD
At 2022-03-3110,659USD
At 2021-03-3115,353USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-04-01 to 2024-03-310USD366
2022-04-01 to 2023-03-3154,506USD365
2021-04-01 to 2022-03-31318,137USD365
2020-04-01 to 2021-03-310USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2024-03-31266,557USD366
2022-04-01 to 2023-03-31-1,606,336USD365
2021-04-01 to 2022-03-31-1,129,186USD365
2020-04-01 to 2021-03-31-14,595USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-03-312,026,173USD
At 2023-03-311,043,437USD
At 2022-03-312,082,902USD
At 2021-03-312,436,594USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2024-03-3181,317USD366
2022-04-01 to 2023-03-3146,723USD365
2021-04-01 to 2022-03-31-35,361USD365
2020-04-01 to 2021-03-31-24,650USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-03-312,482,686USD
At 2023-03-312,207,914USD
At 2022-03-31835,574USD
At 2021-03-31761,242USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-03-31790,626USD
At 2023-03-31353,703USD
At 2022-03-31194,138USD
At 2021-03-31264,749USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2024-03-312,011,689USD366
2022-04-01 to 2023-03-313,268,936USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2024-03-3129,659USD
At 2023-03-31131,474USD
At 2022-03-311,238,316USD
At 2021-03-311,487,683USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-04-01 to 2022-03-311,481,558USD365
2020-04-01 to 2021-03-311,353,458USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-04-01 to 2024-03-31206,374USD366
2022-04-01 to 2023-03-31144,683USD365
2021-04-01 to 2022-03-31846,968USD365
2020-04-01 to 2021-03-31281,962USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-04-01 to 2024-03-31493,839USD366
2022-04-01 to 2023-03-31526,760USD365
2021-04-01 to 2022-03-31680,313USD365
2020-04-01 to 2021-03-31211,037USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-03-3117,709,718shares
At 2023-03-3117,679,618shares
At 2022-03-3117,547,118shares
At 2021-03-3117,145,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-03-31145,257USD
At 2023-03-31277,836USD
At 2022-03-31101,491USD
At 2021-03-31194,590USD
At 2020-03-3160,790USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-03-312,813,431USD
At 2023-03-312,703,081USD
At 2022-03-312,115,207USD
At 2021-03-311,563,472USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-03-31179,191USD
At 2023-03-3197,451USD
At 2022-03-31176,480USD
At 2021-03-31162,145USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-03-31-218,794USD
At 2023-03-31-682,254USD
At 2022-03-31941,400USD
At 2021-03-311,500,493USD
At 2020-03-311,479,810USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-03-31577,665USD
At 2023-03-31523,519USD
At 2022-03-31759,314USD
At 2021-03-311,005,649USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-03-31730,036USD
At 2023-03-31687,543USD
At 2022-03-31848,385USD
At 2021-03-311,035,744USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-03-311,887,458USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-03-3118,601USD
At 2023-03-3122,369USD
At 2022-03-3144,868USD
At 2021-03-3144,868USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-03-3116,206USD
At 2023-03-3117,597USD
At 2022-03-3134,209USD
At 2021-03-3129,515USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-03-31732,552USD
At 2023-03-31652,731USD
At 2022-03-31209,019USD
At 2021-03-3197,238USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-03-31142,859USD
At 2023-03-31116,963USD
At 2022-03-31224,392USD
At 2021-03-31301,370USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-04-01 to 2024-03-31271,275USD366
2022-04-01 to 2023-03-31-2,212,966USD365
2021-04-01 to 2022-03-311,114,446USD365
2020-04-01 to 2021-03-3128,022USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-04-01 to 2024-03-31271,869USD366
2022-04-01 to 2023-03-31-2,204,126USD365
2021-04-01 to 2022-03-31-1,125,565USD365
2020-04-01 to 2021-03-31-28,022USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-04-01 to 2024-03-31353,080USD366
2022-04-01 to 2023-03-31-2,280,506USD365
2021-04-01 to 2022-03-31-1,111,230USD365
2020-04-01 to 2021-03-31-76,727USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2023-04-01 to 2024-03-31302,210USD366
2022-04-01 to 2023-03-31-2,149,257USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2024-03-31897,517USD366
2022-04-01 to 2023-03-31917,773USD365
2021-04-01 to 2022-03-311,042,007USD365
2020-04-01 to 2021-03-31574,634USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-04-01 to 2024-03-312,030USD366
2022-04-01 to 2023-03-313,743USD365
2021-04-01 to 2022-03-314,694USD365
2020-04-01 to 2021-03-315,990USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-04-01 to 2024-03-314,718USD366
2022-04-01 to 2023-03-31-71,150USD365
2021-04-01 to 2022-03-3114,740USD365
2020-04-01 to 2021-03-31-13,427USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2023-04-01 to 2024-03-31-594USD366
2022-04-01 to 2023-03-31-8,840USD365
2021-04-01 to 2022-03-3111,119USD365
2020-04-01 to 2021-03-310USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-04-01 to 2022-03-310USD365
2020-04-01 to 2021-03-310USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-04-01 to 2024-03-3181,317USD366
2022-04-01 to 2023-03-3146,723USD365
2021-04-01 to 2022-03-3135,361USD365
2020-04-01 to 2021-03-3124,250USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-04-01 to 2023-03-31621USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-04-01 to 2024-03-31436,923USD366
2022-04-01 to 2023-03-31174,940USD365
2021-04-01 to 2022-03-31-70,611USD365
2020-04-01 to 2021-03-31-65,142USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-04-01 to 2024-03-31-101,816USD366
2022-04-01 to 2023-03-3178,802USD365
2021-04-01 to 2022-03-31182,531USD365
2020-04-01 to 2021-03-31-162,276USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-04-01 to 2022-03-310USD365
2020-04-01 to 2021-03-31-706USD365

Inspect the source

Entity
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED / CIK 0001672886
Captured
2026-09-21T17:22:51.018Z
SEC response SHA-256
5779345d654e0c5bdccd0db49d6a4f5f72a8525c49074d7feb9e4523f0bd33c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001672886.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))